All In Biotech

Drug Trial Radar · NCT07569926

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

The Impact of Fluciclovine (18F) PET on the Management of Participants With Prostate Cancer Following Negative or Equivocal PSMA PET Imaging at the Time of Biochemical Recurrence

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

142

Planned (sponsor's estimate)

Start

Aug 31, 2026

Primary completion

Dec 31, 2027

Study completion Dec 31, 2032

Sponsor

Lead sponsor
Blue Earth DiagnosticsIndustry
Sponsor type
Industry
First posted
May 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The impact of fluciclovine (18F) PET on the management of participants with prostate cancer following negative or equivocal PSMA PET Imaging at the time of biochemical recurrence

Conditions

  • Prostate Cancer

Interventions

  • fluciclovine (18F)Drug

    fluciclovine (18F) injection, 370 MBq (10 mCi) ± 20%, delivered as an intravenous bolus.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of participants with any recorded Change In Management following a fluciclovine (18F) PET/CT scan.Time frame: fluciclovine (18F) on Day 1, At least 24 hours after the piflufolastat (18F) scan, but within 30 calendar days

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • University of California San Diego Health

    San Diego, California · Not yet recruiting

  • Emory University

    Atlanta, Georgia · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • Washington University

    St Louis, Missouri · Not yet recruiting

  • Oregon Health & Science University

    Portland, Oregon · Recruiting

  • Urology Austin

    Austin, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.